These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 5310124)
1. [Agranulocytosis caused by chloramphenicol. Report of a case]. Teixeira PA; Sernada DF Hospital (Rio J); 1968 Sep; 74(3):845-50. PubMed ID: 5310124 [No Abstract] [Full Text] [Related]
2. [Agranulocytosis caused by chloramphenicol. Presentation of one case]. Teixeira PA; Sernada DF Hospital (Rio J); 1968 Sep; 74(3):845-50. PubMed ID: 5303769 [No Abstract] [Full Text] [Related]
3. [Current aspects of agranulocytosis (15 cases)]. Duhamel G; Najman A; Gorin NC; Stachowiak Ann Med Interne (Paris); 1977 Mar; 128(3):303-6. PubMed ID: 301372 [No Abstract] [Full Text] [Related]
4. [A case of reversible agranulocytosis uring treatment of abscess of the lung. Discussion on the responsible drug]. Chassagnon C; Jocteur-Monrozier D J Med Lyon; 1969 Jun; 50(166):977-8 passim. PubMed ID: 5398662 [No Abstract] [Full Text] [Related]
5. [Impairment of hemopoiesis by chloramphenicol with a description of 2 fatal cases]. Kunchev K; Ribov D Vutr Boles; 1982; 21(3):101-2. PubMed ID: 7113179 [No Abstract] [Full Text] [Related]
6. [Agranulocytosis after chloramphenicol eyedrops]. von Mühlendahl KE Dtsch Med Wochenschr; 1987 Jan; 112(4):158-9. PubMed ID: 3803234 [No Abstract] [Full Text] [Related]
12. [Management of drug-induced agranulocytosis associated with severe septicemia]. Tornóczky J; Tóth A; Balikó Z; Kolumbusz L; Muth L; Kósa Z Orv Hetil; 1985 Jun; 126(22):1349-53. PubMed ID: 3925418 [No Abstract] [Full Text] [Related]
13. [Cytologic changes following stimulation of hematopoiesis]. von Deschwanden P; Buschor O Schweiz Med Wochenschr; 1966 Sep; 96(37):1232-3. PubMed ID: 5994847 [No Abstract] [Full Text] [Related]
14. [Medicamentous agranulocytosis as a manifestation of drug induced disease]. Gracheva NM Ter Arkh; 1974; 46(1):98-105. PubMed ID: 4454002 [No Abstract] [Full Text] [Related]
15. Data on the lack of a particular myelotoxicity of chloramphenicol in Israel. Sheba C; Shani M Haematol Lat; 1969; 12(3):539-42. PubMed ID: 5396825 [No Abstract] [Full Text] [Related]
16. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [TBL] [Abstract][Full Text] [Related]
17. [Chloramphenicol panmyelopathy in a child]. Juchum W Wien Med Wochenschr; 1970 Jul; 120(30):536-42. PubMed ID: 5513642 [No Abstract] [Full Text] [Related]
18. Studies on chloramphenicol. II. Possible determinants and progress of haemopoietic toxicity during chloramphenicol therapy. O'Gorman Hughes DW Med J Aust; 1973 Dec; 2(26):1142-6. PubMed ID: 4777551 [No Abstract] [Full Text] [Related]
19. [Probability of a blood damage by chloramphenicol]. Kopp H; Janz B; Knaust K Ther Ggw; 1969 May; 108(5):764 passim. PubMed ID: 5376948 [No Abstract] [Full Text] [Related]
20. [Agranulocytosis caused by captopril: report of a case]. Ochoa Gómez FJ; Andrés Nilsson C; Salcedo Aguilar J; Campo Hernández JM; Peña Somovilla JL; Márquez de Prado M An Med Interna; 1989 Feb; 6(2):109-10. PubMed ID: 2491070 [No Abstract] [Full Text] [Related] [Next] [New Search]